Rising prevalence of obesity, growing geriatric population with higher risk of heart diseases, and rapid technological advancements to detect arrhythmia are critical factors for the growth of the transseptal access systems market. Introduction of innovative technologies such as left atrial appendage occlusion therapy is benefitting patients who are at high risk of strokes due to non-valvular atrial fibrillation (AF).
Rising prevalence of obesity, growing geriatric population with higher risk of heart diseases, and rapid technological advancements to detect arrhythmia are critical factors for the growth of the transseptal access systems market. Introduction of innovative technologies such as left atrial appendage occlusion therapy is benefitting patients who are at high risk of strokes due to non-valvular atrial fibrillation (AF).
Gain More Insights about this Report
These developments not only prolong survival rate, but also reduce morbidity and enhance the quality of life.
Moreover, reimbursement coverage for cardiac procedures by private and government healthcare insurance providers is expected to significantly boost the growth of the transseptal access systems market. On the back of noteworthy innovations in needles, rapidly increasing sales of transseptal access needles are catalyzing market growth.
To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/18703
The global transseptal access systems market was valued at US$ 638 Mn in 2018 and is expected to witness a CAGR of 9.8% during the forecast period (2019–2029).
Key Takeaways of Transseptal Access Systems Market Study
- Wide adoption of transseptal access sheaths in majority of transseptal procedures for improved left atrium access, tissue contact, maneuverability, and superior clinical outcomes, contributed to the dominance of the segment by product type.
- Introduction of transseptal access systems for atrial fibrillation ablation resulted in high success rates for patients with structural heart disease.
- Owing to rapid installation of transseptal access systems in hospitals for improved healthcare, the segment is expected to hold half of the revenue share in the transseptal access systems market.
- Increasing incidence of heart-related complexities such as atrial fibrillation, continuous evolving reimbursement scenario by service providers, and availability of various players contributed to the dominance of North America in the global transseptal access systems market.
“Launch of new product lines and continuous improvements in available systems have enhanced the safety and efficacy of transseptal access systems. Substantial increase in interest for transseptal heart catheterization is leading to the growth of transseptal access systems market” says a PMR Analyst.
For Critical Insights on the Market, Request For Methodology Here @ https://www.persistencemarketresearch.com/methodology/18703
New Product Launches – Winning Strategy of Leading Transseptal Access System Manufacturers
Continuous up-gradation and innovation in transseptal access systems are responsible for intense competition among players in the transseptal access systems market. Numerous organizations are focusing on new product approvals for transseptal access systems.
For example, in Jan 2019, Baylis Medical launched ExpanSure, a transseptal access system that combines a dilator and sheath into a single device, which assists in larger dilation as compared to fixed curve sheaths.
In 2018, Transseptal Solutions Ltd received FDA approval for the TSP Crosser Transseptal Access System, which is designed to provide stable catheter positioning and controlled access. These winning strategies by leading players are also being followed by regional and local players.
More Valuable Insights on Transseptal Access Systems Market
Persistence Market Research offers a unique perspective and actionable insights on transseptal access systems in its latest study, presenting historical demand assessment from 2014–2018 and projections from 2019–2029, on the basis of product type (transseptal access sheaths and transseptal access needles), application (AF ablation, MV repair, and LAA occlusion), and end user (hospitals, ambulatory surgical centers, and specialty clinics), across five major regions.
For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/18703
COMPANIES COVERED IN TRANS SEPTAL ACCESS SYSTEMS MARKET REPORT
- Terumo Corporation
- Medtronic PLC
- St. Jude Medical (Abbott Laboratories)
- Boston Scientific
- Biosense Webster, Inc. (Johnson & Johnson)
- Merit Medical Systems, Inc.
- Baylis Medical Company Inc.
- Pressure Products Medical Device Manufacturing LLC
- Cook Medical LLC
- ransseptal Solutions, Inc.
More About the Report –
Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet.
The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.
The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Transcatheter Heart Valve Replacement Repair Market – Transcatheter Heart Valve Replacement Repair Market Segmented By Transcatheter Aortic Valve Replacement and Transcatheter Mitral Valve Repair Product in Transfemoral, Transapical and Transaortic Surgical Approach. For More Information
Global Biological Drugs Market - Biological Drugs Market Segmented By Biologic Therapeutic Drugs, Biologic Medicines with Enbrel, Lantus, Neulasta, Avonex, NovoLog Therapeutic Protein. For More Information
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com